Whitehawk Therapeutics, Inc. — Director's Dealing 2023

Apr 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aadi Bioscience, Inc. (AADI)
CIK: 0001422142
Period of Report: 2023-04-03

Reporting Person: Desai Neil (Director, Executive Chairman, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-03	Common Stock	S	9583	$7.446	Disposed	1905960	Indirect
2023-04-04	Common Stock	S	12869	$7.3029	Disposed	1893091	Indirect
2023-04-05	Common Stock	S	7336	$7.235	Disposed	1885755	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	639698	Indirect

Footnotes

F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2: Represents the weighted average share price of an aggregate total of 9,583 shares sold in the price range of $7.29 to $7.59 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

F4: Represents the weighted average share price of an aggregate total of 12,869 shares sold in the price range of $7.20 to $7.40 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F5: Represents the weighted average share price of an aggregate total of 7,336 shares sold in the price range of $7.20 to $7.37 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F6: Shares held by Anishka Irrevocable 2016 Trust dated October 19, 2016 (the "Irrevocable Trust"). The Reporting Person disclaims beneficial ownership of the shares held by the Irrevocable Trust except to the extent of any pecuniary interest therein, and this filing shall not be deemed an admission that Dr. Desai is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.